Metaphore Biotechnologies is harnessing the power of biomimicry and machine learning to unlock the transformative therapeutic potential of functional molecular mimics. The company’s MIMiC™ platform is a computationally driven bioplatform designing new therapeutics where function, specificity, and selectivity can be optimized. Metaphore is focused on making previously intractable drug targets accessible and unlocking breakthroughs that outperform today’s drugs for maximum patient impact.
Metaphore was founded in 2021 in Flagship Labs, a unit of Flagship Pioneering.
Company Details
- Employees
- 55
- Address
- Director Jobs
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://metaphorebio.com/
- Keywords
- Manager jobs.
Metaphore Biotechnologies Questions
Metaphore Biotechnologies's website is https://metaphorebio.com/
Metaphore Biotechnologies's LinkedIn profile is https://www.linkedin.com/company/metaphore-bio
Metaphore Biotechnologies has
55 employees.
View email and phone details for 55
employees at Metaphore Biotechnologies.
Metaphore Biotechnologies's industry is
Biotechnology Research
Metaphore Biotechnologies's top competitors are
Apriori Bio,
Quotient Therapeutics,
Generate:biomedicines,
Ampersand Biomedicines,
Montai Therapeutics,
Flagship Pioneering,
Alnylam Pharmaceuticals,
Tessera Therapeutics,
Alltrna,
Prologue Medicines.
Metaphore Biotechnologies's categories are Biotechnology Research
